These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An update on the pathogenesis of the upper airways in aspirin-exacerbated respiratory disease. Choi JH; Kim MA; Park HS Curr Opin Allergy Clin Immunol; 2014 Feb; 14(1):1-6. PubMed ID: 24300420 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms by which dupilumab normalizes eicosanoid metabolism and restores aspirin-tolerance in AERD: A hypothesis. Picado C; Mullol J; Roca-Ferrer J J Allergy Clin Immunol; 2023 Feb; 151(2):310-313. PubMed ID: 36126795 [TBL] [Abstract][Full Text] [Related]
8. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD. Choi GS; Kim JH; Shin YS; Ye YM; Kim SH; Park HS Clin Exp Allergy; 2013 Jul; 43(7):730-40. PubMed ID: 23786280 [TBL] [Abstract][Full Text] [Related]
9. Trial of thromboxane receptor inhibition with ifetroban: TP receptors regulate eicosanoid homeostasis in aspirin-exacerbated respiratory disease. Laidlaw TM; Buchheit KM; Cahill KN; Hacker J; Cho L; Cui J; Feng C; Chen CC; Le M; Israel E; Boyce JA J Allergy Clin Immunol; 2023 Sep; 152(3):700-710.e3. PubMed ID: 37068712 [TBL] [Abstract][Full Text] [Related]
12. Eosinophil production of prostaglandin D Feng X; Ramsden MK; Negri J; Baker MG; Payne SC; Borish L; Steinke JW J Allergy Clin Immunol; 2016 Oct; 138(4):1089-1097.e3. PubMed ID: 27423494 [TBL] [Abstract][Full Text] [Related]
13. Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics. Adamusiak AM; Stasikowska-Kanicka O; Lewandowska-Polak A; Danilewicz M; Wagrowska-Danilewicz M; Jankowski A; Kowalski ML; Pawliczak R Int Arch Allergy Immunol; 2012; 157(4):354-62. PubMed ID: 22123288 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes. Liu T; Laidlaw TM; Katz HR; Boyce JA Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16987-92. PubMed ID: 24085850 [TBL] [Abstract][Full Text] [Related]
16. Update on recent advances in the management of aspirin exacerbated respiratory disease. Palikhe NS; Kim JH; Park HS Yonsei Med J; 2009 Dec; 50(6):744-50. PubMed ID: 20046412 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. Pérez-Novo CA; Watelet JB; Claeys C; Van Cauwenberge P; Bachert C J Allergy Clin Immunol; 2005 Jun; 115(6):1189-96. PubMed ID: 15940133 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 receptors in asthma and in chronic rhinosinusitis/nasal polyps with and without aspirin hypersensitivity. Machado-Carvalho L; Roca-Ferrer J; Picado C Respir Res; 2014 Aug; 15(1):100. PubMed ID: 25155136 [TBL] [Abstract][Full Text] [Related]
19. Upper airways in aspirin-exacerbated respiratory disease. Choi JH; Kim JH; Park HS Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):21-6. PubMed ID: 25546326 [TBL] [Abstract][Full Text] [Related]
20. Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD. Taniguchi M; Mitsui C; Hayashi H; Ono E; Kajiwara K; Mita H; Watai K; Kamide Y; Fukutomi Y; Sekiya K; Higashi N Allergol Int; 2019 Jul; 68(3):289-295. PubMed ID: 31235242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]